The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

VANCOUVER, BC / ACCESS Newswire / January 22, 2025 / (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)("Onco" or the "Company") is pleased to announce that it has entered into a letter of intent (the "LOI") with ...

Alphabet Inc.’s Google has deepened its commitment to artificial intelligence (AI) by investing an additional $1 billion in ...

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...

NATICK, MASSACHUSETTS / ACCESS Newswire / January 22, 2025 / VALID, a Techbio startup dedicated to reshaping drug discovery ...

VANCOUVER, BC / ACCESS Newswire / January 22, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)("Onco" or the "Company") is pleased to announce that it has entered into a letter of ...

The Pharmaceutical Technology Excellence Awards winners have been announced! Download our full 50+ page report to find out ...

ImmunoPrecise has outperformed the broader market in a spectacular fashion. As of now, IPA’s YTD performance stands at +81.64%, a staggering increase compared to the S&P 500’s YTD performance of just ...

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...